Lung 2024 coming in October

2024-10-04

Lung 2024 is a virtual conference that features state-of-the-art knowledge in the topic of contemporary and practical management of lung diseases and disorders. It takes place on Saturday, October 26, 2024, and is free to attend.

Learning objectives

By reviewing common conditions, we hope to allow the nonspecialist to be more confident and competent in the diagnosis and initial management of respirology.

At the conclusion of this activity, the Learner will be able to:

Provide a summary of updates on common respiratory conditions
Discuss new approaches to diagnosis and management of respiratory conditions
Review the recommendations from current respiratory guidelines

Agenda and registration

Visit www.lung2024.com to review the agenda and register for the conference. You can also review the agenda here.

Disclaimer

This program has received educational grants from: AstraZeneca, Boehringer-Ingelheim, GSK, Merck, Organon, Valeo Pharma.

See also

Asthma exacerbations management A lecture by Dr Paul O’Byrne from McMaster University, Canada, presented at MIRCIM 2024.
Asthma under control: A history of management and revolutionary research
McMaster Perspective Extended Dr Paul O’Byrne from McMaster University provides fresh insight on the evolution of therapeutic approaches in asthma.
Diagnostic workup of eosinophilic bronchitis Can an increased level of eosinophils in the nasal cytology of a person with chronic cough indicate eosinophilic bronchitis as its cause?
Update on parapneumonic effusions Dr Madhu Chari from McMaster University summarizes the latest data on parapneumonic effusions.
When is CT imaging unnecessary? What are the most common reasons for unnecessary CT scan requests and how to avoid them?
Typical features of bronchiectasis Apart from productive cough, what signs and symptoms should suggest the presence of bronchiectasis?
Asthma and NSAIDs Should all patients with asthma be advised to avoid NSAIDs?
Treating COPD: Key messages for everyday practice Dr Jadwiga Wedzicha from Imperial College London, UK, presents key recommendations for the treatment of COPD.

Lung 2024 coming in October

Learning objectives

Agenda and registration

Disclaimer

Social Media